Iniparib (Standard)
Iniparib (Standard) is the analytical standard of Iniparib. This product is intended for research and analytical applications. Iniparib (BSI-201) is an irreversible inhibitor of PARP1, used in the research of triple negative breast cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 98%
- CAS No.: 160003-66-7
- Formule: C7H5IN2O3
- Masse moléculaire:292.03
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureté et documentation
-
Help & FAQs
-
HY-12015
IniparibPARP1 Inhibitor -
HY-10162
OlaparibPARP Inhibitor -
HY-16106
TalazoparibPARP Inhibitor -
HY-10619
NiraparibPARP Inhibitor -
HY-12022
3-AminobenzamidePARP Inhibitor -
HY-10617A
RucaparibPARP Inhibitor -
HY-10129
VeliparibPARP Inhibitor -
HY-10162R
Olaparib (Standard)PARP Inhibitor -
HY-10617
Rucaparib phosphatePARP Inhibitor -
HY-13688A
PJ34PARP Inhibitor -
HY-10619A
Niraparib hydrochloridePARP Inhibitor -
HY-15147
XAV-939Tankyrase Inhibitor
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 160003-66-7
-
Masse moléculaire 292.03
-
Formule C7H5IN2O3
-
SMILES
O=C(C1=CC=C(C([N+]([O-])=O)=C1)I)N
-
Synonyms
BSI-201 (Standard); NSC-746045 (Standard); IND-71677 (Standard)
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Liu X, et al. Iniparib nonselectively modifies cysteine-containing proteins in tumor cells and is not a bona fide PARP inhibitor. Clin Cancer Res. 2012 Jan 15;18(2):510-23. [Content Brief]
[2]. Yin S, et al. Myc mediates cancer stem-like cells and EMT changes in triple negative breast cancers cells. PLoS One. 2017 Aug 17;12(8):e0183578. [Content Brief]
[3]. Ma W, et al. Differential effects of poly(ADP-ribose) polymerase inhibition on DNA break repair in human cells are revealed with Epstein-Barr virus. Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6590-5. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Iniparib (Standard) Related Classifications
HY-12015R Related Classifications
Powered by Bioz